Drug intelligence / Profile preview

Bronchidex

Development stage
Unknown
Lead developer
Stadchem
Modality
Small Molecules
Administration
Oral
01

Overview

Bronchidex is a combination respiratory medication developed and marketed by Stadchem. It is available in two primary formulations: a tablet containing the mucolytic bromhexine hydrochloride, the bronchodilator terbutaline sulfate, and the expectorant guaifenesin; and an oral syrup containing the bronchodilator levosalbutamol sulfate, the expectorant guaifenesin, and the mucolytic ambroxol hydrochloride. Bronchidex is indicated for the symptomatic relief of productive cough, chest congestion, and bronchospasm associated with respiratory conditions such as bronchitis, bronchial asthma, emphysema, smoker's cough, and chronic obstructive pulmonary disease (COPD). The active ingredients work synergistically to thin and loosen thick mucus, facilitate its expulsion from the airways, and relax bronchial smooth muscle to ease breathing.

Brand names
Bronchidex
Other names
Ambroxol + levosalbutamol + guaifenesinBromhexine + guaifenesin + terbutalineBromhexine hydrochloride + terbutaline sulfate + guaifenesinLevosalbutamol sulfate + guaifenesin + ambroxol hydrochloride
02

Targets

ADRB2 (β2)

Beyond the preview

Go deeper on Bronchidex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bronchidex.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call